107 related articles for article (PubMed ID: 2581428)
1. [Clinical evaluation of Cernilton on benign prostatic hyperplasia].
Ueda K; Jinno H; Tsujimura S
Hinyokika Kiyo; 1985 Jan; 31(1):187-91. PubMed ID: 2581428
[TBL] [Abstract][Full Text] [Related]
2. [Clinical evaluation of cernilton in the treatment of the benign prostatic hypertrophy].
Horii A; Iwai S; Maekawa M; Tsujita M
Hinyokika Kiyo; 1985 Apr; 31(4):739-46. PubMed ID: 2412423
[TBL] [Abstract][Full Text] [Related]
3. [Clinical evaluation of Cernilton in benign prostatic hypertrophy].
Hayashi J; Mitsui H; Yamakawa G; Suga A; Kai A; Shimabukuro T; Yanagi K; Fujisawa S; Takihara H; Kaneda Y
Hinyokika Kiyo; 1986 Jan; 32(1):135-41. PubMed ID: 2421560
[TBL] [Abstract][Full Text] [Related]
4. [Clinical evaluation of Cernilton on benign prostatic hypertrophy--a multiple center double-blind study with Paraprost].
Maekawa M; Kishimoto T; Yasumoto R; Wada S; Harada T; Ohara T; Okajima E; Hirao Y; Ohzono S; Shimada K
Hinyokika Kiyo; 1990 Apr; 36(4):495-516. PubMed ID: 1696065
[TBL] [Abstract][Full Text] [Related]
5. [A comparative study on different doses of cernilton for preventing the clinical progression of benign prostatic hyperplasia].
Xu J; Qian WQ; Song JD
Zhonghua Nan Ke Xue; 2008 Jun; 14(6):533-7. PubMed ID: 18649754
[TBL] [Abstract][Full Text] [Related]
6. [A long-term therapeutic experience with Cernilton in chronic prostatitis].
Jodai A; Maruta N; Shimomae E; Sakuragi T; Shindo K; Saito Y
Hinyokika Kiyo; 1988 Mar; 34(3):561-8. PubMed ID: 3389296
[TBL] [Abstract][Full Text] [Related]
7. [Use of cernilton in the therapy of prostatic adenoma and chronic prostatitis].
Shaplygin LV; Sivakov AA
Urologiia; 2007; (3):35-7, 39. PubMed ID: 17722618
[TBL] [Abstract][Full Text] [Related]
8. Cernilton for benign prostatic hyperplasia.
Wilt T; Mac Donald R; Ishani A; Rutks I; Stark G
Cochrane Database Syst Rev; 2000; (2):CD001042. PubMed ID: 10796739
[TBL] [Abstract][Full Text] [Related]
9. WITHDRAWN: Cernilton for benign prostatic hyperplasia.
Wilt TJ; Macdonald R; Ishani A; Rutks I; Stark G
Cochrane Database Syst Rev; 2011 May; 2011(5):CD001042. PubMed ID: 21563128
[TBL] [Abstract][Full Text] [Related]
10. [Cernilton in the treatment of prostatic adenoma and chronic prostatitis].
Aslamazov EG; Akhvlediani ND; Vinarov AZ; Aliaev IuG
Urologiia; 2007; (1):52, 54-6. PubMed ID: 17472001
[TBL] [Abstract][Full Text] [Related]
11. [Fushile: a safe and effective therapeutic for benign prostatic hyperplasia].
Shang XJ; Liu ZY; Liu ZF; Sun YH; Huang YF
Zhonghua Nan Ke Xue; 2008 Mar; 14(3):227-30. PubMed ID: 18488335
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of Cernilton in the treatment of benign prostatic hyperplasia.
Dutkiewicz S
Int Urol Nephrol; 1996; 28(1):49-53. PubMed ID: 8738619
[TBL] [Abstract][Full Text] [Related]
13. [Conservative treatment of benign prostatic hypertrophy: reevaluation of the effect of eviprostat by subjective symptoms and uroflowmetry].
Matsuura T; Wakabayashi A; Kaneko S; Kurita T
Hinyokika Kiyo; 1986 Jun; 32(6):903-6. PubMed ID: 2429533
[TBL] [Abstract][Full Text] [Related]
14. Dietary supplements for benign prostatic hyperplasia: an overview of systematic reviews.
Kim TH; Lim HJ; Kim MS; Lee MS
Maturitas; 2012 Nov; 73(3):180-5. PubMed ID: 22883375
[TBL] [Abstract][Full Text] [Related]
15. [Clinical study of Eviprostat for the treatment of benign prostatic hyperplasia].
Song Y; Li NC; Wang XF; Ma LL; Wan B; Hong BF; Na YQ
Zhonghua Nan Ke Xue; 2005 Sep; 11(9):674-6. PubMed ID: 16209208
[TBL] [Abstract][Full Text] [Related]
16. [Therapeutic effect of Robaveron tablet (KN-7) on urinary disturbance by benign prostatic hypertrophy].
Sonoda T; Endo H; Maru A; Sasaki K; Kuroda K; Takamura T; Inada F; Rokuzyo M; Ohori T; Kubo T
Hinyokika Kiyo; 1985 Mar; 31(3):553-62. PubMed ID: 2411118
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of combined therapy with terazosin and tolteradine for patients with lower urinary tract symptoms associated with benign prostatic hyperplasia: a prospective study.
Yang Y; Zhao XF; Li HZ; Wang W; Zhang Y; Xiao H; Zhang X
Chin Med J (Engl); 2007 Mar; 120(5):370-4. PubMed ID: 17376305
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis and management of benign prostatic hyperplasia.
Edwards JL
Am Fam Physician; 2008 May; 77(10):1403-10. PubMed ID: 18533373
[TBL] [Abstract][Full Text] [Related]
19. [Results of a double-blind study on the effectiveness of ERU (extractum radicis Urticae) capsules in conservative treatment of benign prostatic hyperplasia].
Vontobel HP; Herzog R; Rutishauser G; Kres H
Urologe A; 1985 Jan; 24(1):49-51. PubMed ID: 2580383
[TBL] [Abstract][Full Text] [Related]
20. A pollen extract (Cernilton) in patients with inflammatory chronic prostatitis-chronic pelvic pain syndrome: a multicentre, randomised, prospective, double-blind, placebo-controlled phase 3 study.
Wagenlehner FM; Schneider H; Ludwig M; Schnitker J; Brähler E; Weidner W
Eur Urol; 2009 Sep; 56(3):544-51. PubMed ID: 19524353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
